[1]石秋月 常静 毛敏.肾动脉粥样硬化性狭窄患者肾动脉支架植入术的研究进展[J].心血管病学进展,2023,(5):406.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.006]
　SHI Qiuyue,CHANG Jing,MAO Min.Renal Artery Stent Placement in Patients with Atherosclerotic Renal Artery Stenosis[J].Advances in Cardiovascular Diseases,2023,(5):406.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.006]
点击复制

肾动脉粥样硬化性狭窄患者肾动脉支架植入术的研究进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2023年5期
页码:
406
栏目:
综述
出版日期:
2023-05-25

文章信息/Info

Title:
Renal Artery Stent Placement in Patients with Atherosclerotic Renal Artery Stenosis
作者:
石秋月 常静 毛敏
?重庆医科大学附属第一医院心血管内科,重庆 400010)
Author(s):
SHI Qiuyue;  CHANG Jing;  MAO Min
(Department of Cardiology,The First Affiliated Hospital of Chongqing Medical University,Chongqing 400010,China)
关键词:
肾动脉粥样硬化性狭窄; 肾动脉支架植入术; 血压; 肾功能; 肾血流储备分数
Keywords:
Atherosclerotic renal artery stenosis; Renal artery stent placement; Blood pressure; Renal function; Renal fractional flow reserve
DOI:
10.16806/j.cnki.issn.1004-3934.2023.05.006
摘要:
随着社会经济的快速发展，肾动脉粥样硬化性狭窄的患病率逐渐上升，已成为继发性高血压的重要组成部分之一。由于肾动脉粥样硬化性狭窄在发展过程中会影响心血管和肾脏等重要脏器，导致严重的并发症甚至死亡，因此及时发现该类患者并进行早期干预显得尤为重要，但如何进行干预存在许多争议，肾动脉支架植入术的运用时机和疗效问题并未得到良好解决。现阐述关于肾动脉粥样硬化性狭窄患者的肾动脉支架植入术治疗相关进展。
Abstract:
With the rapid development of social economy,the prevalence of atherosclerotic renal artery stenosis has gradually increased and has become one of the important components of secondary hypertension. Atherosclerotic renal artery stenosis will affect cardiovascular,kidney and other important organs in the development process,leading to serious complications and even death. It is particularly important to identify such patients time ly and carry out intervention early,but there are many disputes about how to intervene. The problem s of the timing and efficacy of renal artery stent placement has not been resolved properly. This review aims to illustrate the relevant progress of renal artery stent placement in atherosclerotic renal artery stenosis patients

参考文献/References:

[1] 蒋雄京,邹玉宝. 肾动脉狭窄的诊断和处理中国专家共识[J]. 中国循环杂志,2017,32(9):835-844.

[2] Peng M,Jiang XJ,Dong H,et al. Etiology of renal artery stenosis in 2047 patients:a single-center retrospective analysis during a 15-year period in China[J]. J Hum Hypertens,2016,30(2):124-128.

[3] Dobrek L. An outline of renal artery stenosis pathophysiology—A narrative review[J]. Life(Basel),2021,11(3):208.

[4] Bokhari MR,Bokhari SRA.Renal artery stenosis[M]. 2022 Sep 6. In: StatPearls [Internet]. Treasure Island (FL):StatPearls Publishing; 2023 Jan–. PMID: 28613469.

[5] Lenz T,Schulte KL. Current management of renal artery stenosis[J]. Panminerva Med,2016,58(1):94-101.

[6] Zeller T,Macharzina R,Rastan A,et al. Renal artery stenosis:up-date on diagnosis and treatment[J]. Vasa,2014,43(1):27-38.

[7] Noory E,Sritharan K,Zeller T. To stent or not to stent? Update on revascularization for atherosclerotic renovascular disease[J]. Curr Hypertens Rep,2016,18(6):45.

[8] Patel SM,Li J,Parikh SA. Renal artery stenosis:optimal therapy and indications for revascularization[J]. Curr Cardiol Rep,2015,17(9):623.

[9] Wheatley K,Ives N,Gray R,et al. Revascularization versus medical therapy for renal-artery stenosis[J]. N Engl J Med,2009,361(20):1953-1962.

[10] Bax L,Woittiez AJ,Kouwenberg HJ,et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function:a randomized trial[J]. Ann Intern Med,2009,150(12):840-848.

[11] Cooper CJ,Murphy TP,Cutlip DE,et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis[J]. N Engl J Med,2014,370(1):13-22.

[12] Chrysant GS,Bates MC,Sullivan TM,et al. Proper patient selection yields significant and sustained reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension:long-term results from the HERCULES trial[J]. J Clin Hypertens(Greenwich),2014,16(7):497-503.

[13] Kim S,Kim MJ,Jeon J,et al. Effects of percutaneous angioplasty on kidney function and blood pressure in patients with atherosclerotic renal artery stenosis[J]. Kidney Res Clin Pract,2019,38(3):336-346.

[14] Wolak T,Belkin A,Ginsburg V,et al. Does percutaneous transluminal renal artery angioplasty improve blood pressure control and renal function in patients with atherosclerotic renal artery stenosis?[J]. Isr Med Assoc J,2011,13(10):619-624.

[15] Liao CJ,Yang BZ,Wang ZG. Percutaneous transluminal renal angioplasty with stent is effective for blood pressure control and renal function improvement in atherosclerotic renal artery stenosis patients[J]. Chin Med J(Engl),2012,125(8):1363-1368.

[16] Jujo K,Saito K,Ishida I,et al. Efficacy of 24-hour blood pressure monitoring in evaluating response to percutaneous transluminal renal angioplasty[J]. Circ J,2016,80(9):1922-1930.

[17] Reinhard M,Schousboe K,Andersen UB,et al. Renal artery stenting in consecutive high-risk patients with atherosclerotic renovascular disease:a prospective 2-center cohort study[J]. J Am Heart Assoc,2022,11(7):e24421.

[18] Zeller T,Krankenberg H,Erglis A,et al. A randomized,multi-center,prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis(RADAR)—One-year results of a pre-maturely terminated study[J]. Trials,2017,18(1):380.

[19] Catena C,Colussi G,Brosolo G,et al. Long-term renal and cardiac outcomes after stenting in patients with resistant hypertension and atherosclerotic renal artery stenosis[J]. Kidney Blood Press Res,2017,42(5):774-783.

[20] Vassallo D,Ritchie J,Green D,et al. The effect of revascularization in patients with anatomically significant atherosclerotic renovascular disease presenting with high-risk clinical features[J]. Nephrol Dial Transplant,2018,33(3):497-506.

[21] Misra S,Khosla A,Allred J,et al. Mortality and renal replacement therapy after renal artery stent placement for atherosclerotic renovascular disease[J]. J Vasc Interv Radiol,2016,27(8):1215-1224.

[22] Hirsch AT,Haskal ZJ,Hertzer NR,et al. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease(lower extremity,renal,mesenteric,and abdominal aortic):a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery,Society for Cardiovascular Angiography and Interventions,Society for Vascular Medicine and Biology,Society of Interventional Radiology,and the ACC/AHA Task Force on Practice Guidelines(writing committee to develop guidelines for the management of patients with peripheral arterial disease)—Summary of recommendations[J]. J Vasc Interv Radiol,2006,17(9):1383-1397,1398.

[23] Klein AJ,Jaff MR,Gray BH,et al. SCAI appropriate use criteria for peripheral arterial interventions:an update[J]. Catheter Cardiovasc Interv,2017,90(4):E90-E110.

[24] Prince M,Tafur JD,White CJ. When and how should we revascularize patients with atherosclerotic renal artery stenosis?[J]. JACC Cardiovasc Interv,2019,12(6):505-517.

[25] Cuspidi C,Tadic M,Sala C,et al. Left ventricular mass reduction and hypertrophy regression following renal artery revascularization:a meta-analysis[J]. J Hypertens,2021,39(1):4-11.

[26] Zhuang B,Wang S,Zhao S,et al. Computed tomography angiography-derived fractional flow reserve(CT-FFR) for the detection of myocardial ischemia with invasive fractional flow reserve as reference:systematic review and meta-analysis[J]. Eur Radiol,2020,30(2):712-725.

[27] Mitchell JA,Subramanian R,White CJ,et al. Predicting blood pressure improvement in hypertensive patients after renal artery stent placement:renal fractional flow reserve[J]. Catheter Cardiovasc Interv,2007,69(5):685-689.

[28] Kadziela J,Witkowski A,Januszewicz A,et al. Assessment of renal artery stenosis using both resting pressures ratio and fractional flow reserve:relationship to angiography and ultrasonography[J]. Blood Press,2011,20(4):211-217.

[29] K?dziela J,Januszewicz A,Prejbisz A,et al. Prognostic value of renal fractional flow reserve in blood pressure response after renal artery stenting(PREFER study)[J]. Cardiol J,2013,20(4):418-422.

[30] K?dziela J,Prejbisz A,Micha?owska I,et al. Relationship between hemodynamic parameters of renal artery stenosis and the changes of kidney function after renal artery stenting in patients with hypertension and preserved renal function[J]. Blood Press,2015,24(1):30-34.

[31] Kapoor N,Fahsah I,Karim R,et al. Physiological assessment of renal artery stenosis:comparisons of resting with hyperemic renal pressure measurements[J]. Catheter Cardiovasc Interv,2010,76(5):726-732.

[32] Leertouwer TC,Gussenhoven EJ,van Overhagen H,et al. Stent placement for treatment of renal artery stenosis guided by intravascular ultrasound[J]. J Vasc Interv Radiol,1998,9(6):945-952.

[33] Kawasaki D,Fujii K,Fukunaga M,et al. Safety and efficacy of carbon dioxide and intravascular ultrasound-guided stenting for renal artery stenosis in patients with chronic renal insufficiency[J]. Angiology,2015,66(3):231-236.

[34] Chrysochou C,Mendichovszky IA,Buckley DL,et al. BOLD imaging:a potential predictive biomarker of renal functional outcome following revascularization in atheromatous renovascular disease[J]. Nephrol Dial Transplant,2012,27(3):1013-1019.

[35] Gloviczki ML,Lerman LO,Textor SC. Blood oxygen level-dependent(BOLD) MRI in renovascular hypertension[J]. Curr Hypertens Rep,2011,13(5):370-377.

[36] Lin Z,Zhang B,Lin L,et al. Prediction of split renal function improvement after renal artery stenting by blood oxygen level-dependent magnetic resonance imaging[J]. Front Cardiovasc Med,2022,9:793777.

相似文献/References:

[1]卡迪热亚·木它里甫 刘凯.肾动脉粥样硬化性狭窄诊治进展[J].心血管病学进展,2023,(7):589.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.004]
　Kadireya·Mutalifu LIU Kai.Advances in Treatment and Diagnosis for Atherosclerotic Renal Artery Stenosis[J].Advances in Cardiovascular Diseases,2023,(5):589.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.004]

更新日期/Last Update: 2023-06-29